If this is your first visit, be sure to check out the FAQ in HCMA Announcements. You may have to register before you can post: click the register link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below. Your Participation in this message board is strictly voluntary. Information and comments on the message board do not necessarily reflect the feelings, opinions, or positions of the Hypertrophic Cardiomyopathy Association. At no time should participants to this board substitute information within for individual medical advice. The Hypertrophic Cardiomyopathy Association shall not be liable for any information provided herein. All participants in this board should conduct themselves in a professional and respectful manner. Failure to do so will result in suspension or termination. The moderators of the message board working with the HCMA will be responsible for notifying participants if they have violated the rules of conduct for the board. Moderators or HCMA staff may edit any post to ensure it conforms with the rules of the board or may delete it. This community is welcoming to all those with HCM we ask that you remember each user comes to the board with information and a point of view that may differ from that which you hold, respect is critical, please post respectfully. Thank you

Announcement

Collapse
No announcement yet.

Pirfenidone to Treat Hypertrophic Cardiomyopathy

Collapse

About the Author

Collapse
Wayne Find out more about Wayne
X
Collapse
 
  • Page of 1
  • Filter
  • Time
  • Show
Clear All
new posts
Previous template Next
  • #1

    Pirfenidone to Treat Hypertrophic Cardiomyopathy

    Does anyone have any information regarding this trial proceedure at N.I.H. The drug is also called Deskar.
    Tags: None
  • #2
    Re: Pirfenidone to Treat Hypertrophic Cardiomyopathy

    Dear Wayne,

    THe NIH recently disbanded its HCM clinic. Can you be more specific--is this an older study you just read about or is it something new? etc

    S

    Comment

    • #3
      Re: Pirfenidone to Treat Hypertrophic Cardiomyopathy

      Hi,

      I got curious, so I poked around. I found the NIH clinical trial, but it closed on April 12th this year. It is not clear if or when any results will be published from what I could find.

      However, from another web site, it seems that "Pirfenidone is an orally active small molecule drug that appears to inhibit collagen synthesis, down regulate production of multiple cytokines and block fibroblast proliferation and stimulation in response to cytokines. Pirfenidone, which has demonstrated activity in multiple fibrotic indications, is currently in Phase II clinical development for fibrotic diseases of the lung, kidney and liver. Investigational, not an FDA approved indication."

      Basically, this means that the drug reduces collagen buildup and is being studied. Preliminary results in mice show that it can reduce liver cirrhosis (sp?).

      How is this relevant to HCM? In SOME --big emphasis on SOME-- genetic mutations of HCM cause collagen to deposit in between the muscle cells, which is why we get hypertrophy and those disorganized cells. So if you could reduce the fibrosis (what those deposits are called) then you would have a non-surgical way of reducing the hypertrophy --in theory.

      It is a long, long way from being put to use or even proven to work.

      But here's hoping!!

      S

      Comment

      Previous template Next
      Working...
      X